Massachusetts Life Sciences center (MLsc)
The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, education, research & development, and commercialization. The MLSC is charged with implementing a $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences.
Synopsys technology is at the heart of innovations that are changing the way we live and work. The Internet of Things. Autonomous cars. Wearables. Smart medical devices. Secure financial services. Machine learning and computer vision. These breakthroughs are ushering in the era of Smart, Secure Everything―where devices are getting smarter, everything’s connected, and everything must be secure.
Powering this new era of technology are advanced silicon chips, which are made even smarter by the remarkable software that drives them. Synopsys is at the forefront of Smart, Secure Everything with the world’s most advanced tools for silicon chip design, verification, IP integration, and application security testing. Our technology helps customers innovate from Silicon to Software, so they can deliver Smart, Secure Everything.
Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.
Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, we also established ourselves as a leader in the field of multiple sclerosis. In 2016, our focus expanded to include Sanofi’s programs in oncology and immunology.
Our approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, we rapidly grew to become one of the world’s leading biotechnology companies, recognized for our pioneering development of treatments for rare genetic disorders and our innovative contributions to medical science and biomanufacturing.
MathWorks is the leading developer of mathematical computing software for engineers and scientists. Founded in 1984, MathWorks employs over 3500 people in 15 countries, with headquarters in Natick, Massachusetts, U.S.A.
DAVIS helps job seekers find contract, contract-to-hire and direct hire positions within fantastic companies, all while providing comprehensive staffing solutions. Our dedication to quality, relationships, and innovation have earned us many accolades and long-term rapport with both candidates and clients.
The year we opened our doors Marty McFly was attempting to get back to the future, Bruce Springsteen's Born in the U.S.A. became the best-selling album, Super Mario Bros broke out in the States, and Commodore released its Amiga personal computer.
1985 was a great year in popular culture and an even better year for DAVIS companies. For 30 years we’ve been specializing in staffing for Engineering,Professional, Advanced Manufacturing, and Software.